News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anchor Therapeutics Adds Global Experts to Board of Directors and Scientific Advisory Board


7/21/2010 12:41:38 PM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anchor Therapeutics today announced the appointment of Robert Kamen, Ph.D., past President of Abbott Bioresearch Center, to its Board of Directors. Anchor is developing a new class of therapeutic candidates, called pepducins, to allosterically modulate G protein coupled receptors (GPCRs) on the inside surface of the cell membrane, representing a novel approach to this important target class.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES